A detailed history of Rock Springs Capital Management LP transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 5,629,239 shares of CMPX stock, worth $8.39 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
5,629,239
Previous 5,513,788 2.09%
Holding current value
$8.39 Million
Previous $5.51 Million 87.87%
% of portfolio
0.35%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.8 - $1.88 $92,360 - $217,047
115,451 Added 2.09%
5,629,239 $10.4 Million
Q1 2023

May 15, 2023

BUY
$3.14 - $5.48 $567,084 - $989,688
180,600 Added 3.39%
5,513,788 $18 Million
Q3 2022

Nov 14, 2022

BUY
$1.9 - $3.37 $9,690 - $17,187
5,100 Added 0.1%
5,333,188 $12.2 Million
Q4 2021

Feb 14, 2022

BUY
$2.88 - $3.98 $15.3 Million - $21.2 Million
5,328,088 New
5,328,088 $16.9 Million

Others Institutions Holding CMPX

About Compass Therapeutics, Inc.


  • Ticker CMPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 101,285,000
  • Market Cap $151M
  • Description
  • Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...
More about CMPX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.